Celgene and Galapagos to Collaborate on siRNA Target Discovery | GenomeWeb

NEW YORK, Nov. 18 (GenomeWeb News) - Celgene and Galapagos Genomics today announced a multi-year target discovery collaboration.

 

Under terms of the agreement, Galadeno, Galapagos' wholly owned services unit, will provide Celgene with its adenoviral SilenceSelect siRNA and FleXSelect cDNA libraries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.